Page last updated: 2024-10-25

clofibrate and Non-alcoholic Fatty Liver Disease

clofibrate has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"Several parameters related to NAFLD were evaluated in both plasma and livers from fetuses of 21 days of gestation and 140-day-old offspring."1.56The offspring from rats fed a fatty diet display impairments in the activation of liver peroxisome proliferator activated receptor alpha and features of fatty liver disease. ( Fornes, D; Heinecke, F; Jawerbaum, A; Mazzucco, MB; Roberti, S; White, V, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Heinecke, F1
Mazzucco, MB1
Fornes, D1
Roberti, S1
Jawerbaum, A1
White, V1

Other Studies

1 other study available for clofibrate and Non-alcoholic Fatty Liver Disease

ArticleYear
The offspring from rats fed a fatty diet display impairments in the activation of liver peroxisome proliferator activated receptor alpha and features of fatty liver disease.
    Molecular and cellular endocrinology, 2020, 07-01, Volume: 511

    Topics: Animals; Clofibrate; Diet, High-Fat; Female; Fetus; Gene Expression Regulation; Lipid Metabolism; Li

2020